Graves Disease Clinical Trials in Asheville, North Carolina

4 studies are recruiting for graves disease in Asheville, North Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

    The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Site-038, Asheville, North Carolina
    Locations
    56 in total
    Run by
    Biohaven Therapeutics Ltd.

    See if you can join NCT07661056 on ClinicalTrials.gov

  2. A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

    The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how it changes antibody …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Asheville Clinical Research, Asheville, North Carolina
    Locations
    32 in total
    Run by
    argenx

    See if you can join NCT07570316 on ClinicalTrials.gov

  3. A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old

    In this study, researchers will learn more about the use of felzartamab in participants with Graves' Disease, also known as GD. GD is an autoimmune disease, which means the body's immune system attacks its own healthy cells. In people with GD, the immune system produces abnormal antibodies, called …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Asheville Clinical Research, Asheville, North Carolina
    Locations
    11 in total
    Run by
    Biogen

    See if you can join NCT07722546 on ClinicalTrials.gov

  4. A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

    This is a study to assess the efficacy, safety, and tolerability of IMVT-1402 in adult participants with Graves' disease (GD) who are hyperthyroid despite antithyroid drug (ATD) treatment. The primary objective of this study is to evaluate the efficacy of IMVT-1402 versus placebo as assessed by T3 …

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Site Number - 1051, Asheville, North Carolina
    Locations
    134 in total
    Run by
    Immunovant Sciences GmbH

    See if you can join NCT06727604 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.